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Lifestyle behaviours have been closely linked to the progressive cell damage associated with oxidative stress (OS) and the
development of cardiovascular disease (CVD). Early detection of lifestyle-linked OS may therefore be useful in the early
identification of prodromal disease. To test this hypothesis, this study assessed the relationship between a comprehensive redox
balance lifestyle score (RBLS) and carotid intima-media thickness (CIMT), a recognized marker for CVD, and plasma
biomarkers of OS. In a cross-sectional study design, 100 apparently healthy middle-aged participants were asked to complete a
comprehensive lifestyle questionnaire, followed by DXA scanning, CIMT ultrasonography, and blood collection. The RBLS was
composed of lifestyle components with pro- and antioxidant properties with a higher score indicative of lower oxidative activity.
Multiple linear regression and logistic regression analysis were performed for statistical analysis. The RBLS was significantly
associated with the risk for increased CIMT that was independent of conventional CVD risk factors (χ2 9 = 35 60, P ≤ 0 001).
The adjusted model explained 42.4% of the variance in CIMT. Participants with RBLS below the median were at
significantly increased risk of higher CIMT compared to participants with RBLS above the median (OR = 3 60, 95% CI:
1.19–10.88, P = 0 023). Significant associations were also observed between the RBLS, plasma total antioxidant capacity
(TAC) (r 99 = 0 28, P = 0 006), hydroperoxide (HPX) (rs 99 = −0 28, P = 0 005), TAC/HPX ratio (r 98 = 0 41, P ≤ 0 001),
γ-glutamyltransferase (r 97 = −0 23, P = 0 024), uric acid (r 98 = −0 20, P = 0 045), and inflammatory C-reactive protein
(rs 97 = −0 25, P = 0 012) and interleukin-1β (r 97 = −0 21, P = 0 040). These findings highlight the importance of identifying
the collective influence of lifestyle behaviours on OS activity and its potential to remodel the vascular endothelium.
1. Introduction
Cardiovascular diseases (CVDs) are the leading causes of
death globally accounting for almost 30% of deaths world-
wide [1]. The development of CVDs has a generally long pro-
dromal period with clinical symptoms only becoming
apparent after considerable damage, and remodelling has
already occurred in the vascular endothelium. It has been
shown that carotid intima-media thickness (CIMT) ultraso-
nography represents a sensitive and reliable method to detect
the presence and progression of subclinical vascular changes
that if left unchecked portend CVD [2]. However, in a recent
study, more than half of CIMT variance was not explained by
conventional cardiovascular risk factors such as dyslipidae-
mia [3]. Unfortunately, biochemical abnormalities such as
high plasma total cholesterol are now recognized as down-
stream secondary pathologies, not as primary initiators of
the disease process and therefore may not closely reflect
actual disease, particularly in the early stages [4]. Thus, the
identification of biomarkers for which the change more spe-
cifically represents the disease process and is therefore more
indicative of the presence of tissue damage is needed.
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It has been shown that biochemical changes associated
with redox imbalance and oxidative stress are associated
with the endothelial remodelling involved in atherosclero-
sis and increased CIMT [5, 6]. In addition, it has been
reported that biomarkers of oxidative stress are signifi-
cantly associated with the risk of atherosclerosis and
CIMT even after controlling for conventional risk factors
[7]. In other words, while generally not included in rou-
tine pathology measures such as plasma lipid profile, this
chronic subclinical disease process may be detected via
changes in oxidative stress biomarkers. This is consistent
with the observation that oxidized low-density lipoprotein
cholesterol (LDL-C) has been shown to be more athero-
genic than native LDL-C [4]. Therefore, including a mea-
sure of oxidative stress in any risk assessment tool may
add further value to the current set of conventional risk
factors used for disease prediction and prognosis.
The role of unhealthy lifestyle behaviours as primary
driving forces behind the development of CVDs has been
well established [1]. Continuous exposure to unhealthy life-
style behaviours, with high prooxidant and low antioxidant
potentials, has been shown to significantly affect the redox
balance causing oxidative stress and subsequent chronic cell
damage [8]. Through years of chronic exposure, this damage
accumulates and gradually drives the body toward a diseased
phenotype [9]. Therefore, an early evaluation of the effect of
lifestyle behaviours on the redox balance may be helpful in
assessing whether an individual’s lifestyle is driving their bio-
chemistry toward either health or disease.
Much of the literature addressing the association between
lifestyle behaviours, CVD risk, and oxidative stress has
focused on the independent effects of individual lifestyle
behaviours [10–14]. However, considering the potential
for complex interactions between multiple lifestyle factors
[15–17], a combination of several oxidative stress-related
lifestyle factors, as a unified score, may be more strongly
associated with health outcomes than any individual fac-
tor. While some studies have developed indices or scores
that account for multiple lifestyle components, assessments
of their effects on redox balance have been limited to life-
style components such as dietary antioxidants/prooxidants,
smoking, and medication use [18, 19]. In addition, their
assessments have yielded conflicting results [18]. More
importantly, none has investigated the association between
an oxidative stress-related lifestyle score and a subclinical
indicator of CVD, such as high CIMT. Hence, the associ-
ations between a redox balance lifestyle score, the risk for
higher CIMT, and biomarkers of oxidative stress remain
unclear. Therefore, in this study, we aimed to examine
the association between a more comprehensive lifestyle
score that included lifestyle factors previously shown to
influence redox balance (i.e., redox balance lifestyle score
(RBLS)) and risk for higher CIMT as a recognized subclin-
ical marker for CVD. Secondarily, we investigated whether
this RBLS also correlates with plasma biomarkers of oxida-
tive stress and other conventional risk factors for athero-
sclerosis in otherwise healthy subjects. To the best of our
knowledge, this is the first study to investigate these asso-
ciations in an apparently healthy cohort.
2. Materials and Methods
2.1. Participants. In this cross-sectional study, 100 apparently
healthy subjects (48 males and 52 females), aged between 40
and 75 years, were recruited at Sydney Adventist Hospital
and the University of New South Wales campuses. After
obtaining a written informed consent, participants were
asked to complete a series of questionnaires for the assess-
ment of their lifestyle behaviours. Participants were asked
to recall their lifestyle behaviours over the past four months.
All questionnaires (except dietary questionnaires) were com-
pleted online a maximum of two weeks before the blood
collection and physiological assessments. Hard copies of die-
tary questionnaires were completed on the same day as the
blood collection and physiological assessments. Blood collec-
tion, blood pressure measurement, and body scanning for
visceral adipose tissue (VAT) fat mass analysis were all
performed on the same day in a fasted state (about 12
hours). Ethical approval of the study was obtained from
the Adventist HealthCare Limited Human Research Ethics
Committee, Sydney Adventist Hospital, Australia (HREC
number: 2013-022).
2.2. Biochemical Analysis. Plasma total antioxidant capacity
and reactive oxygen species (in the form of hydroperoxides)
were measured indirectly using the FORD (free oxygen
radicals defence) and the FORT (free oxygen radical test)
colorimetric assays (CR3000, Callegari Srl., Catellani Group,
Parma, Italy), as previously described [20]. Plasma C-reactive
protein (CRP) levels were quantified by immunoturbidi-
metric assay on a Roche/Hitachi cobas c system (Sydney
Adventist Hospital pathology laboratory). Plasma tumour
necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and IL-6
levels were measured using the MILLIPLEX® MAP human
high-sensitivity T-cell magnetic bead panel immunoassay
(Merck KGaA, Darmstadt, Germany).
Measurements of fasting plasma glucose (FPG), total
cholesterol (TC), high-density lipoprotein cholesterol
(HDL-C), triglyceride (TG), uric acid (UA), and γ-glutamyl-
transferase (GGT) levels were conducted by the Sydney
Adventist Hospital pathology laboratory on a Roche/Hitachi
cobas c system using the enzymatic method. Plasma-glycated
hemoglobin A1c (HbA1c) concentration was measured by
ion-exchange high-performance liquid chromatography
(HPLC) on the D-100 hemoglobin testing system (Bio-Rad
Laboratories, Hercules, CA, USA).
Low-density lipoprotein cholesterol (LDL-C) levels were
calculated by the Friedewald equation [21]. TyG index was
calculated as the ln [fasting triglycerides (mmol/L)× fasting
glucose (mmol/L)/2] [22].
2.3. Visceral Fat Mass Analysis. Dual-energy X-ray absorpti-
ometry (DXA) method was used to measure VAT fat mass by
a Lunar iDXA (GE Healthcare, Madison, WI, USA) with an
automatic total-body scan mode and enCORE software (ver-
sion 16, GE Healthcare, Madison, WI, USA). After being
changed into a standard cloth gown, participants were cor-
rectly centred on the scanning table in a supine position
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and then were scanned by a trained operator according to the
standard methods previously described [23].
2.4. Common Carotid Intima-Media Thickness (CIMT)
Measurement. IMT measurements of the right common
carotid artery (CCA) were obtained after placing the partici-
pant in a supine position and having them rotate their neck
to the left. Orientation to the CCA was achieved by first using
a transversal scanning view from the base of the neck to the
carotid bifurcation. At approximately 1 cm below the bifur-
cation, the transducer was rotated to obtain a longitudinal
image of the vessel. At least three representative measure-
ments of CIMT were made in the far wall in the most thick-
ened area of each vessel, while plaques were not included.
The mean of these three measurements was then calcu-
lated and reported in the study. Optimal B-mode settings
for gain, depth, and focal zone placement were adjusted
to enhance arterial wall structures and image quality for
each individual. IMT was measured by manually applying
electronic callipers [24].
2.5. Questionnaires. For assessing dietary and alcohol intake,
the validated 74-item Cancer Council Victoria Dietary Ques-
tionnaire for Epidemiological Studies Version 2 (DQES v2)
[25] was used. The evaluation of caffeine intake, physical
activity level, sitting time, depression, anxiety and stress,
sleep quality, and sleep apnoea risk was conducted by using
the validated Stanford questionnaire [26], International
Physical Activity Questionnaire (IPAQ)—long version [27],
Depression Anxiety Stress Scale-21 (DASS-21) question-
naire; Pittsburgh Sleep Quality Index (PSQI) [29], and Berlin
questionnaires [30], respectively.
2.6. Statistical Analysis. The Shapiro-Wilk and Kolmogorov-
Smirnov tests were applied to test the normality of the
variables. After checking graphical displays and applying
appropriate statistical rules, the following outliers were
removed: one outlier was removed from the data for each
of the variables stress score, anxiety score, sitting time,
intakes of lycopene, α-carotene, β-carotene, polyunsaturated
fatty acid (PUFA), iron, vitamin E and alcohol, plasma IL-6,
TNF-α, TAC, and hydroperoxide. Therefore, n = 99 for each
of these variables. In addition, one outlier was removed and
one missing value was reported for the variable carotid
intima-media thickness resulting in n = 98 for this variable.
Two outliers were removed for the variables PSQI, depres-
sion score, intakes of caffeine and β-cryptoxanthin, plasma
uric acid, and carotenoid resulting in n = 98 for each of these
variables. Three outliers were removed for the variables vita-
min C intake, VAT fat mass, plasma IL-1β, TG, CRP, GGT,
and TG/HDL-C resulting in n = 97 for each of these vari-
ables. Correlations between variables were analyzed using
Pearson’s (r n ) or Spearman’s (rs n ) correlation coeffi-
cients, as deemed appropriate. Multiple linear regression
analysis was performed to examine the association between
the RBLS and plasma levels of oxidative stress and inflam-
matory markers as well as other biochemical marker levels,
after adjustment for age and gender. The Levene’s test of
equality was used to check the homogeneity of variances
between groups. If normality tests for the variables or
multiple linear regression models were significant, then
an appropriate transformation of the data was performed
so that normality assumptions were satisfied. Transforma-
tion techniques included base-10 log-transformed means,
square roots, or reciprocal roots.
Logistic regression analysis was used to examine the asso-
ciation between the high CIMT risks and the RBLS. The
median value was used to dichotomize the CIMT measure.
Also, in order to allow a quantitative comparison of risks in
persons at different ends of the exposure distribution, the
RBLS was divided into two categories. All models were exam-
ined for collinearity among the independent variables. Line-
arity of any continuous independent variables and the logit
transformation of the dependent variable were checked using
the Box-Tidwell procedure. Whenever the distribution of a
variable was significantly different from the normal distribu-
tion, we transformed that variable by using the power of 2 or
the square root of the related independent variables was used.
The results of the logistic regression models were expressed as
adjusted odds ratios (ORs) and 95% CIs. All statistical analy-
ses were performed using SPSS version 23 for Windows. P
values less than 0.05 were considered statistically significant.
2.7. Redox Balance Lifestyle Score Definition. The redox bal-
ance lifestyle score (RBLS) was developed with reference to
the previously validated oxidative balance score (OBS) [18].
OBS was comprised of lifestyle components with prooxidant
and antioxidant properties including nutritional subcompo-
nents, alcohol intake, smoking, and medication and supple-
ment use. In order to provide a better estimation of the
redox balance state, additional lifestyle behaviours with
established evidence of their association with oxidative stress
were included in the score calculation. These include intakes
of transfatty acids [31] and caffeine [15]; psychological
wellness [13]; sleeping behaviours [14]; physical activity
[10]; and, for the first time, a measure of VAT fat mass,
a well-known prooxidant risk factor for NCDs [32]. As
all participants had been asked to stop taking medications
or supplements at least two weeks prior to testing day, we
did not take into account medication or supplement use.
The total score ranged from 4.54 to 9.05 points, with a
higher score reflecting a better redox balance state
(Table 1). All continuous score variables were divided into
tertiles on the basis of the distribution of these variables
among the participants of the study. The exception was for
alcohol intake that was categorized as abstainer, one drink
per day, and greater than 1 drink per day intakes, due to a sig-
nificant number of abstainers in the cohort. The qualitative
variable of apnoea risk was divided into two categories (low
and high) based on the related questionnaire’s scoring sys-
tem. The smoking history cutoffs were defined by assigning
one point to current smokers, two points to ever smokers,
and three points to never smokers. Subjects who had values
for components with antioxidant properties in the first, sec-
ond, and third tertiles were assigned one, two, and three
points, respectively. Subjects who had values for components
with prooxidant properties in the first, second, and third
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tertiles were assigned three points, two points, and one point,
respectively (Table 1).
In order to calculate the final RBLS, a raw score was first
calculated for each person for each lifestyle component based
on the scoring system described above. The raw score for
each lifestyle component was then weighted by multiplying
it by the (absolute) correlation coefficient of the association
between the relevant component and the plasma TAC/HPX
ratio (Table 1), a meaningful measure of redox balance
[33]. Importantly, the potential for prooxidant effects due
to excess antioxidant vitamin intake (e.g., vitamin E, vitamin
C, or β-carotene) was accounted for by assigning a value of
one to intakes higher than levels previously linked to oxida-
tive activity [34, 35] for the related antioxidant. However,
in this cohort, antioxidant vitamin intake values were below
these pro-oxidant-linked values.
3. Results
Among a total of 100 subjects, 48 were males. Participant
characteristics for individual components and their associa-
tion with the redox balance lifestyle score (RBLS) are shown
in Table 2. The participants’ possible score can range between
4.54 (least healthy) and 9.05 (most healthy). The overall
mean± SD for the RBLS for the cohort was 6.69± 0.90.
Statistically significant correlations were found between
individual components and the overall RBLS as shown in
Table 2. β-Carotene intake had the strongest association
Table 2: Participant characteristics for individual components of the RBLS and their association with the RBLS.
Characteristic n Mean ± SD Correlation coefficient with RBLS
Lifestyle score (RBLS) 100 6.69± 0.90 —
Age 100 55.98± 8.83 −0.09
VAT fat mass (g) 97 953.12± 798.26 −0.27∗
PUFA intake (g/day) 99 11.5± 5.65 0.12
Trans FA intake (g/day) 100 0.38± 0.31 −0.05
Iron intake (mg/day) 99 12.13± 4.44 −0.05
Vitamin E intake (mg/day) 99 7.09± 2.83 0.32∗
Vitamin C intake (mg/day) 97 105.54± 46.80 0.37∗
α-Carotene intake (μg/day) 99 714.03± 418.73 0.48∗
β-Carotene intake (μg/day) 99 3784.80± 1819.34 0.51∗
Lycopene intake (μg/day) 99 5143.93± 2639.29 0.04
Lutein and zeaxanthin intake (μg/day) 100 1011.88± 447.43 0.50∗
β-Cryptoxanthine intake (μg/day) 98 236.27± 172.67 0.38∗
Caffeine intake (mg/day) 98 303.06± 320.63 −0.40∗a
Alcohol intake (g/day) 99 7.57± 10.72 −0.32∗a
Smoking history 100 −0.17a
Current smoker 0
Ever smoker 74
Never smoker 26
Physical activity (%) 100 0.28∗a
Sedentary/low 20
Moderate 43
High 35
Sitting time (min/day/week) 99 399.78± 154.34 −0.21∗a
Depression score 98 2.46± 3.01 −0.38∗a
Stress score 99 4.76± 3.25 −0.32∗a
Anxiety score 99 1.56± 1.76 −0.15a
PSQI 97 4.34± 2.95 −0.50∗a
Apnoea risk (%) 100 0.44∗a
High risk 20
Low risk 80
RBLS: redox balance lifestyle score; VAT: visceral adipose tissue; PUFA: polyunsaturated fatty acids; PSQI: Pittsburgh sleep quality index. Comparisons were
made using Pearson’s correlation unless otherwise stated; acomparisons were made using Spearman’s correlation; ∗P < 0 05.
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while transfatty acid and iron intakes had the weakest
associations with the RBLS.
3.1. Association between the Redox Balance Lifestyle Score
(RBLS) and Carotid Intima-Media Thickness (CIMT).
Table 3 shows the logistic regression analysis results for the
association between redox balance lifestyle score (RBLS)
and risk of higher CIMT. The logistic regression analysis
showed that after adjustment for age and gender, there was
a statistically significant (χ2 3 = 23 61, P ≤ 0 001) associa-
tion between CIMT and the RBLS that explained 28.6%
(Nagelkerke R2) of the variance in CIMT. Those with scores
below the median (i.e., ≤6.68) were at significantly increased
risk of higher CIMT compared to those with scores above the
median (OR = 4 11, 95% CI: 1.57–10.75, P = 0 004).
Importantly, these associations remained significant after
additional adjusting for conventional atherosclerosis risk fac-
tors including systolic and diastolic blood pressures, LDL-
cholesterol, eGFR, FPG, and TG/HDL-C (χ2 9 = 35 60, P
≤ 0 001), where the adjusted model then explained 42.4%
(Nagelkerke R2) of the variance in CIMT. After adjustment,
those with the RBLS below the median (i.e., ≤6.68) were at
a significantly increased risk of higher CIMT compared to
participants with scores above the median (OR = 3 60, 95%
CI: 1.19–10.88, P = 0 023).
3.2. Association between the Redox Balance Lifestyle Score
(RBLS) and Oxidative Stress and Inflammatory Markers.
Table 4 shows the associations between the RBLS and
levels of plasma biomarkers of oxidative stress and inflam-
mation. A statistically significant positive association was
observed between the RBLS and total antioxidant capacity
(TAC) (r 99 = 0 28, P = 0 006). Since the residuals for the
linear regression model were not normally distributed when
gender was included, the association between the RBLS and
plasma TAC was analyzed separately for each gender. The
results showed that after controlling for age, there was a statis-
tically significant association between the RBLS and TAC in
males (t 45 = 3 71, P = 0 001, R2 = 0 20) but not in females
(t 48 = 0 98, P ≥ 0 05, R2 = −0 02). A statistically significant
negative association was observed between the RBLS and
plasma hydroperoxide levels (rs 99 = −0 28, P = 0 005). This
association remained significant after the adjustment for age
and gender (t 95 = −3 02, P = 0 003, R2 = 0 31).
There was a statistically significant negative association
between the RBLS and the plasma oxidative stress-
associated enzyme GGT (r 97 = −0 23, P = 0 024). This
association remained significant after adjustment for age
and gender (t 93 = −2 31, P = 0 023, R2 = 0 10).
The RBLS was significantly negatively associated with
plasma uric acid (r 98 = −0 20, P = 0 045). This associa-
tion remained significant after age and gender adjustment
(t 94 = −2 43, P = 0 017, R2 = 0 30).
As anticipated, the RBLS was statistically significantly
associated with the TAC/HPX ratio (r 98 = 0 41, P ≤
0 001), an index of redox balance (Figure 1). This associa-
tion remained significant after adjustment for age and
gender (t 94 = 4 40, P ≤ 0 001, R2 = 0 20).
There was a statistically significant negative associa-
tion between the RBLS and the plasma inflammatory
marker IL-1β (r 97 = −0 21, P = 0 04). This association
did not remain significant after adjustment for age and
Table 3: Mean carotid intima-media thickness (CIMT) and logistic
regression analysis for the association between an RBLS of ≤6.68
and the chance of CIMT > 0 70mm.
(a)
Mean ± SD (n = 98)
CIMT (mm) 0.76± 0.18
(b)
OR (95% CI) P value R2 χ2
Model A 4.11 (1.57–10.75) 0.004 28.6% 23.61
Model B 3.60 (1.19–10.88) 0.023 42.4% 35.60
Model A: adjusted for age and gender; model B: adjusted for age, gender,
systolic blood pressures, diastolic blood pressures, low-density lipoprotein
cholesterol, estimated glomerular filtration rate (eGFR), fasting plasma
glucose, and triglyceride/high-density lipoprotein cholesterol ratio; RBLS:
redox balance lifestyle score.
Table 4: Correlation coefficients and P values for the associations
between RBLS and plasma biomarkers of oxidative stress,
inflammation, and other biochemical markers.
Correlation coefficient P value
Oxidative stress biomarkers
TAC (mmol/L) 0.28 0.006
HPX (mmol/L) −0.28a 0.005
GGT (U/L) −0.23 0.024
Uric acid (mmol/L) −0.20 0.045
TAC/HPX 0.41 ≤0.001
Inflammatory biomarkers
IL-1β (pmol/L) −0.21 0.040
CRP (mg/L) −0.25a 0.012
TNF-α (pmol/L) −0.06 NS
IL-6 (pmol/L) −0.10a NS
Other biochemical markers
TC (mmol/L) −0.34 ≤0.001
LDL-C (mmol/L) −0.32 0.001
HDL-C (mmol/L) 0.12 NS
TG (mmol/L) −0.32a 0.002
FPG (mmol/L) −0.30 0.003
HbA1c (mmol/mol) −0.23 0.025
TG/HDL −0.27 0.008
TyG index −0.40 ≤0.001
RBLS: redox balance lifestyle score; TAC: total antioxidant capacity; HPX:
hydroperoxide; GGT: γ-glutamyltransferase; IL-1β: interleukin-1β; CRP:
C-reactive protein; TNF-α: tumour necrosis factor-α; TC: total cholesterol;
LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density
lipoprotein cholesterol; TG: triglyceride; FPG: fasting plasma glucose;
HbA1c: glycated hemoglobin A. Comparisons were made using Pearson’s
correlation unless otherwise stated; acomparisons were made using
Spearman’s correlation.
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gender (t 93 = −2 06, P ≥ 0 05, R2 = 0 05). The RBLS was
also significantly associated with the acute-phase plasma
inflammatory protein CRP (rs 97 = −0 25, P = 0 012). How-
ever, this association did not remain significant after age and
gender adjustment (t 93 = −2 36, P ≥ 0 05, R2 = 0 04).
No significant association was observed between the
RBLS and plasma TNF-α (r 99 = −0 06, P ≥ 0 05) and
IL-6 (r 98 = −0 07, P ≥ 0 05).
3.3. Association between the RBLS and Routine Pathology
Biomarkers. A statistically significant negative association
was observed between the RBLS and both plasma cholesterol
(r 100 = −0 34, P ≤ 0 001) and LDL-C levels (r 100 = −
0 32, P = 0 001). Both of these associations remained signifi-
cant after adjustment for age and gender (t 96 = −3 63, P
≤ 0 001, R2 = 0 12 and t 96 = −3 42, P = 0 001, R2 = 0 11,
resp.). There was no significant association between the RBLS
and plasma HDL-C (r 100 = 0 12, P ≥ 0 05).
There was a statistically significant inverse association
between the RBLS and plasma triglycerides (rs 97 = −
0 32, P = 0 002). This association remained significant
after adjusting for age and gender (t 93 = −3 81, P ≤
0 001, R2 = 0 15).
A statistically significant inverse association was observed
between the RBLS and both plasma glucose (r 100 = −0 30,
P = 0 003) and HbA1c (r 95 = −0 23, P = 0 025). After
adjustment for age and gender, the association between
RBLS and plasma glucose remained significant (t 96 = −
3 22, P = 0 002, R2 = 0 12). However, the association between
RBLS and plasma HbA1c did not remain significant after
adjustment for age and gender (t 91 = −2 39, P ≥ 0 05,
R2 = 0 05).
Not surprisingly, a strong inverse association was
observed between the RBLS and the plasma TG/HDL-C ratio
(a measure of insulin resistance) (r 97 = −0 27, P = 0 008).
This association remained significant after adjusting for age
and gender (t 91 = −2 99, P = 0 004, R2 = 0 22).
Furthermore, a strong inverse association was observed
between the RBLS and plasma TyG index (an additional
measure of insulin resistance) (r 100 = −0 40, P ≤ 0 001).
Since the residuals for the linear regression model were
not normally distributed when gender was included, the
association between the RBLS and plasma TyG index
was analyzed separately for each gender. The results
showed that after controlling for age, there was a statisti-
cally significant association between the RBLS and TyG
index in both males (t 45 = −3 53, P ≤ 0 001, R2 = 0 18)
and females (t 49 = −2 60, P = 0 012, R2 = 0 09).
4. Discussion
Oxidative stress (OS), defined as an imbalanced state
between an organ’s exposure to reactive oxygen species and
the body’s compensatory antioxidant defence [36], is a recog-
nized player in the progressive cell damage involved in the
development of CVD [4]. The specific impact of individual
lifestyle components, with both pro- and antioxidant ele-
ments, on oxidative stress and the consequent development
of several diseases including CVD have been a focus of atten-
tion in the literature for some time [10, 37–39]. However, as
suggested by some investigators, it is not the individual but
the cumulative action of all lifestyle factors working together
that eventually affects the redox balance and determines an
individual’s risk of disease. In this context, some studies have
reported associations between a composite lifestyle score and
increased risk for several diseases [40, 41]. However, assess-
ments of multiple lifestyle elements have been limited to a
score comprising only a few pro- and antioxidant lifestyle
factors with uncertain effect on oxidative stress biomarkers
[18, 19]. Furthermore, no study has yet assessed the associa-
tion between a composite oxidative stress-related lifestyle
score and the subclinical vascular changes represented by
CIMT. While one large study has reported an association
between a seven-point cardiovascular health score and
CIMT, its assessment was limited to only four lifestyle com-
ponents with no reference to oxidative stress [42]. Therefore,
in this study, we aimed to assess the association between a
more comprehensive redox balance lifestyle score (RBLS)
and CIMT. We also investigated the association between
RBLS, oxidative stress and inflammatory biomarkers.
As expected, significant correlations were observed
between individual lifestyle components and the overall
RBLS (Table 2). All significant associations were in accor-
dance with expected direction, with poorer lifestyle habits
associated with increased oxidative stress.
In order to compare CIMT risks in subjects at different
ends of the score distribution, the RBLS and CIMT values
were divided into two groups using median values as the cut-
offs. Logistic regression analysis showed that a lower RBLS
was associated with a higher CIMT risk after adjusting for
age and gender. More surprisingly, this association remained
significant after further adjusting for conventional athero-
sclerosis risk factors including systolic and diastolic blood
pressures, LDL-cholesterol, eGFR, FPG, and TG/HDL-C
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Figure 1: Association between the redox balance lifestyle score
(RBLS) and plasma redox balance indicator of the TAC/HPX ratio.
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ratio. Subjects with scores below the median were 3.60 times
more likely to exhibit thicker CIMT than subjects with scores
above the median. As the oxidative modification hypothesis
of atherosclerosis suggests, it is the accumulation of the oxi-
dized LDL-C, not the native state of LDL-C, that is athero-
genic [4]. This is consistent with our finding that the
association between the RBLS and CIMT was independent
of the conventional atherosclerosis risk factors such as
LDL-C. While others have reported associations between
CIMT, individual lifestyle behaviours, and a seven-point car-
diovascular health score [42–45], to the best of our knowl-
edge, this is the first study to report the association between
a composite redox balance lifestyle score and CIMT.
We observed a significant positive association between
the RBLS and total antioxidant capacity (TAC) that was
independent of age in males but not in females. Consistent
with this finding, in one study, the combination of both
physical activity and adherence to a healthy diet was
associated with high plasma TAC values [17]. We also
observed a significant negative association between the
RBLS and plasma lipid hydroperoxide levels, which was
independent of age and gender. Similar to our finding,
Lakkur et al. showed that their suggested oxidative balance
score (OBS) was inversely associated with lipid peroxida-
tion biomarker of F2-isoprostanes [18].
As anticipated, our results showed a strong positive asso-
ciation between the RBLS and the TAC/HPX ratio, an effec-
tive index of redox balance, which was independent of age
and gender. This supports the view that various lifestyle
behaviours may synergistically shift the body’s biochemistry
toward an imbalanced redox state and consequent oxidative
stress. While no study has yet reported associations between
TAC/HPX ratio and a comprehensive lifestyle score, our lab
has previously reported on the correlation between individ-
ual lifestyle components and the TAC/HPX ratio, a redox
balance index, using the same cohort [33].
Elevated plasma GGT levels have been suggested as an
early biomarker of oxidative stress [46] and more impor-
tantly are associated with CIMT [47]. Consistent with this,
we found a significant negative association between the RBLS
and plasma GGT levels that was independent of age and gen-
der. In agreement with this finding, in one study, a negative
association was reported between an oxidative balance score
(comprising BMI, nutrition, physical activity, and smoking
components) and plasma GGT levels [19].
Elevated plasma uric acid levels have been shown to pos-
sess prooxidant properties in CVD [48] and also to be an
independent risk factor for increased CIMT [49]. We were
therefore not surprised to find a significant negative associa-
tion between the RBLS and plasma uric acid levels. Consis-
tent with this finding, one study has previously reported
significant associations between plasma uric acid levels and
individual lifestyle components such as BMI, nutrition, and
physical activity [50].
It is recognized that oxidative stress and inflammation
are interrelated. Oxidative stress can trigger an inflammatory
response, which, in turn, can be a direct inducer of oxidative
stress [51, 52]. Consistent with this, we observed a significant
negative association between the RBLS and the plasma
inflammatory marker IL-1β and also a significant negative
association between the RBLS and the acute-phase plasma
inflammatory protein CRP, which were both dependent on
age and gender. Similarly, Lakkur et al. showed a significant
association between an oxidative balance score (OBS) and
plasma CRP [53].
Our results showed that the RBLS was associated not only
with oxidative stress and inflammatory biomarkers but also
with routine pathology lipid biomarkers. Significant negative
associations were observed between the RBLS and plasma
levels of total cholesterol and LDL-C that were both indepen-
dent of age and gender. This finding is consistent with the
results of a population-based study by Lakkur et al. in which
OBS was significantly associated with plasma total choles-
terol and LDL-C [53]. Consistent with Lakkur et al. [53],
our data also showed no significant association between the
RBLS and plasma HDL-C. We observed a strong negative
association between the RBLS and plasma TG levels that
was independent of age and gender. Similarly, in one
study, a healthy lifestyle score (comprising BMI, nutrition,
physical activity, and smoking components) was reported
to be negatively associated with plasma TG in young Aus-
tralian adults [54].
We observed a statistically significant negative associa-
tion between the RBLS and plasma glucose, independent of
age and gender, and HbA1c, which was dependent on age
and gender. A number of other studies have shown a negative
association between lifestyle scores (comprising components
such as BMI, nutrition, and physical activity) and plasma glu-
cose and HbA1c levels [54–56]. These results suggest an
interrelationship between oxidative stress and plasma bio-
marker levels in response to lifestyle.
In further support of the role for oxidative stress in the
development of CVD and related comorbidities, we observed
strong negative and independent associations between the
RBLS and surrogate markers of insulin resistance, triglycer-
ide to HDL-C ratio (TG/HDL-C), and TyG index [22, 57].
Consistent with this finding, other studies have shown nega-
tive associations between healthy lifestyle scores (comprising
components such as BMI, nutrition, and physical activity,
smoking, social support, and sleep) and plasma levels of insu-
lin [54, 55, 58].
In light of findings from a recent study in which more
than half of the CIMT variance was not explained by con-
ventional cardiovascular risk factors, additional contribu-
tors need to be identified [3]. Oxidative stress biomarkers
have been previously shown to be significantly associated
with the risk of atherosclerosis and increased CIMT after
controlling for conventional risk factors of atherosclerosis
[7]. As the RBLS in our study was associated with the risk
of higher CIMT independent of conventional CVD risk
factors and was also associated with oxidative stress bio-
markers, it can be suggested that oxidative stress bio-
markers may contribute to this role. Lifestyle factors with
more prooxidant and less antioxidant properties can syn-
ergistically work together to shift the body’s biochemistry
toward a state of oxidative stress, which can cause subclin-
ical changes in CIMT and gradually lead to the tissue
remodelling associated with CVD.
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While the conclusions in this study are robust, our study
had some limitations. First, the cross-sectional design of the
study does not allow confirmation of causality, but can gen-
erate hypotheses and thus stimulate future research. Also
the relatively small number of subjects may decrease the
sensitivity for identification of relationships with small effect
sizes. Future longitudinal studies overcoming these limita-
tions are required to verify the consistency of our observa-
tions. As lifestyle behaviour information was self-reported,
measurement error and misclassification may occur. While
validated questionnaires were applied to lessen such limita-
tions, assessing exposures over a four-month period was
another limitation of this study when long-term exposures
may be more relevant to the development of atherosclerosis.
Therefore, future studies overcoming these limitations are
recommended.
5. Conclusion
In this study, for the first time, we showed significant associ-
ations between a composite redox balance lifestyle score
(RBLS), risk for increased CIMT, and biomarkers of oxida-
tive stress and inflammation in otherwise healthy subjects.
Our findings provide further support for the role of multiple
lifestyle factors influencing oxidative activity and the devel-
opment of CVD. This suggests that monitoring oxidative
activity may help with early identification of individuals at
risk of CVD, allowing the institution of on-time, targeted,
lifestyle-linked risk modifications.
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